CGTX

arsenal_pianist

Doesn't $CGTX have a catalyst coming up on 10/20?

Asleep-Procedure-131

Os of 6/26/2026 CGTX is included in Russell3000 ...The standard practice across biotech and small cap companies is to issue a Russell press release immediately — because it's considered material news for shareholders, it's a legitimate positive development, and frankly most small cap management teams take every opportunity to generate positive press coverage. Companies like D-Wave Quantum, i-80 Gold, Security National Financial — none of these are companies with sophisticated investor relations philosophies. They all issued press releases immediately. It's almost reflexive at the small cap level. The Case For Your Theory — Management Conservatism There are actually some signals in CGTX's history that support the idea that Ricciardi runs a deliberately conservative investor relations program: Signal 1 — The June 24 FDA minutes framing: When the FDA written minutes dropped June 24 — the most important milestone in the company's history — the press release was measured and precise. No hyperbole. No "transformative" language. Just the facts of what the FDA confirmed. That's unusual restraint for a small cap biotech that could have generated enormous retail excitement with more aggressive language. Signal 2 — The 89% figure handling: The 89% hallucination and delusion slowing figure has been mentioned in one press release — but CGTX has never issued a dedicated press release specifically spotlighting that number with full statistical context. They're holding it for AAIC London. A company trying to pump its stock would have issued three separate press releases about that number by now. Signal 3 — The Expanded Access Program: The Expanded Access Program was extended in February 2026 — allowing real-world DLB patients continued access to zervimesine. Most companies would have issued a press release framing this as evidence that patients and physicians are so convinced of the drug's benefit they're requesting continued access. CGTX disclosed it quietly in a routine update. Signal 4 — No ATM share sales at the bottom: When the stock was at $0.29 — a desperate cash position for most small cap biotechs — CGTX did not aggressively use its $75 million ATM offering to sell shares at catastrophically dilutive prices. They preserved shareholder value even under severe financial pressure. Signal 5 — Insider buying not publicized: When the CFO bought 10,000 shares on earnings day and the CEO bought 9,175 shares in April — neither purchase was accompanied by any press release drawing attention to it. They filed the Form 4 as required and said nothing else. A company trying to inflate its stock would have issued a press release saying "our executives are so confident they're buying shares with their own money." The Counter-Argument — Why It's Probably Not the Primary Reason Here's the uncomfortable alternative explanation: if CGTX was never previously in the Russell 3000, they may simply have never had the opportunity to issue such a press release before. The stock at $0.29 was disqualified on both price and market cap grounds. There was nothing to announce. And if June 2026 is genuinely their first inclusion — they may have missed the announcement window. The preliminary Russell list was posted in late May 2026. CGTX was simultaneously managing: The May 20 FDA Type B meeting The June 24 written minutes press release preparation The June 16 patent announcement The June 17 annual shareholder meeting AAIC abstract preparation for July A small investor relations team managing that many simultaneous material events may simply have deprioritized the Russell announcement — not out of philosophical conservatism but out of bandwidth constraints. The Most Interesting Interpretation — Deliberate Sequencing Here's a third possibility that combines both explanations and is actually the most strategically sophisticated reading: Lisa Ricciardi may have deliberately chosen not to issue a Russell press release now — in order to bundle it with the AAIC London announcement in two weeks. Think about what that press release could look like on July 12-15: "Cognition Therapeutics presents DLB psychosis data at AAIC London showing 89% slowing of hallucinations and delusions. The company also announces its first-ever inclusion in the Russell 3000 Microcap Index, expanding institutional investor eligibility as the company prepares for its Phase 3 DLB registrational trial." That's a much more powerful press release than either announcement made separately. The Russell inclusion provides institutional credibility context for the scientific data. The scientific data provides substance for what would otherwise be a routine index announcement. Together they create a narrative of a company arriving at institutional maturity at precisely the moment its most important clinical data is being presented to the world's leading dementia researchers. If that's the strategy — it's genuinely sophisticated investor relations management. Not overpromising. Not artificially inflating. Just sequencing legitimate positive developments for maximum coherent narrative impact.

happy123z

CING, ACHV, RXRX, DRTS/DRTSW a million times, RVPH, CGTX

arsenal_pianist

No kidding. I got rug pulled by CGTX today. down 10k. It hurt. But... I'm still in, losses aren't losses until you sell. We'll find more money tomorrow.

Siriricu20

CGTX is the way to go

HoosierDaddy1775

Do we think this CGTX news fuels a pump? https://finance.yahoo.com/healthcare/articles/cognition-therapeutics-aligns-key-aspects-113000634.html

Siriricu20

CGTX is green let’s go

Siriricu20

CGTX lets goooo

Mycryptoaccount_idk

CGTX shows promise, I’ve been looking into it recently

Mycryptoaccount_idk

Anyone know anything about $CGTX

Robert_C6190

Anything in regards to CGTX and the upcoming minutes for their DLB w/ Psychosis registration pathway?

happy123z

MUU, SNXX, KORU until the end of the year? Haha or CGTX, FATN, PAIN \[fr\]

Asleep-Procedure-131

Of course there is risk involved in investing, that is why I have analized CGTX on a molecular level. 💋

Asleep-Procedure-131

You are not looking at the fine details. 1. Institutional ownership surging to 43.35% From effectively unknown to nearly half the company owned by sophisticated money. That's not random — it's the result of everything else on this list being recognized by people who manage billions. 2. 86% efficacy signal Not a marginal improvement. Not "trending positive." 86% slowing on NPI-12 with statistically significant results on hallucinations (p=.021) and anxiety (p=.008) in a disease where every existing treatment is either dangerous or ineffective. That's a transformative clinical signal. 3. Two institutional conferences in June Jefferies June 4 — done. H.C. Wainwright June 15 — coming. The same story being told to two different institutional audiences in the same month the FDA written minutes arrive. The timing is deliberate and precise. 4. The team is solid CEO who negotiated a $1 billion deal with Roche. CMO with 17 years at Acorda. CFO with public biotech experience. EY auditing the books for six consecutive years. All three personally buying shares with their own money in April. 5. BIOS Capital actively involved Not a passive index holder. A concentrated $272 million fund that chose CGTX as one of only six positions — with advisory personnel "spending substantial time actively involved in portfolio company operations." They're not watching. They're helping build.

Busy_Radio6183

CGTX: participating in multiple upcoming conference. Really hope for more than a stock to go up. Multiple family members & friends had / currently have Lewy bodies, Alzheimer’s or Parkinson’s. A cure would be better than a stock price here ❤️

Interesting_Part_130

CGTX Anyone?

fungoodtrade

I dipped out of CGTX for a loss (for now, still on my watchlist), Still in SANA watching for super cheap LEAPS, I saw the shares were deeply discounted rn. as someone else mentioned... these are speculative companies that will have a huge upside if the follow through is there.

EffectiveSlacker

Cognition Therapeutics (NASDAQ:CGTX) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.05) by 80 percent. This is a 94.12 percent increase over losses of $(0.17) per share from the same period last year.

EffectiveSlacker

Cognition Therapeutics GAAP EPS of -$0.32 beats by $0.07 CGTX lets goooo

EffectiveSlacker

NRXP CGTX!!! Lets go FEMY BOIS

EffectiveSlacker

CGTX!!

Moon-Monkey6969

I have the same feelings and will invest in DRTS. I also invest in CGTX with the same belief that the Alzheimers drug showing positive results in trials will help the many.

GodLovesYou-

Thanks so much for this helpful inclusion! I agree and will look into mementine also. That is an advantageous perspective concerning CGTX

Immediate_Impress880

BDTX ANNX AVXL CGTX some interesting bio pennies I found

EffectiveSlacker

CGTX - a stock that has been accumulating by investors. Worth a watch

EffectiveSlacker

Omg favourable news for us CGTX shareholders Cognition Therapeutics Presents Promising Phase 2 Results of Zervimesine for Dementia With Lewy Bodies at AD/PD 2026 Conference

ColRizz

CGTX

Trading_4_Kabob

This mornings CGTX news will likely allow for some gains in the coming month but it’s more of a long position IMO.

Trading_4_Kabob

Check out CGTX, I’ve been long on it and regulatory paths just became far more likely. https://finance.yahoo.com/news/cognition-therapeutics-advancing-zervimesine-ct1812-123000241.html

42percentBicycle

CGTX expanding drug use for DLB Psychosis. Could see some action today [Cognition Therapeutics Advancing Zervimesine (CT1812) for Dementia with Lewy Bodies (DLB) Psychosis | Cognition Therapeutics, Inc.](https://ir.cogrx.com/press_releases/cognition-therapeutics-advancing-zervimesine-ct1812-for-dementia-with-lewy-bodies-dlb-psychosis/)

Shaikinbacon

CGTX is about to pop. Maybe. Who knows. I’m drowning but keep buying. 🤙🏼

georgesalad111111

Are you still invested in CGTX?

42percentBicycle

CGTX update from yesterday isn't a huge catalyst but it is positive in that they've improved their EAP. Good time to get in while it's so cheap [Cognition Therapeutics Extends Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies](https://finance.yahoo.com/news/cognition-therapeutics-extends-expanded-access-123000035.html)

Unit_Weird

Lot of great tech stocks going under $1 XPON, GPRO,, CGTX m

SpeedPsychological89

Will add more CGTX under 1

Regular_Hawk8513

Might as well average down on my bio tech holds, CGTX,IBRX and SLS

Austin_Destroyer

Next week, we'll see Cognition Therapeutics CGTX post minutes following their discussion with the FDA about their Alzheimer's drug, Zervimesine. It's a type C meeting and they are probably trying (again) to get fast track or breakthrough designation. It'll be pretty wild if they pull it off.

krol_borsukow

CGTX for me

Hungry-Back-5031

CGTX 🤑

ProfessionalYard7165

Probably HGRAF or CGTX

TurnAroundBroski

This is my second bio stock. My last one I doubled my profits. It was CGTX which I still strongly believe in. They had very strong p2 results, can’t wait for p3

Austin_Destroyer

CGTX. I've had to bury some grandparents in the last year. The memories toward the end aren't great ones -- dementia fucking sucks. I look forward to CT1812 phase 3 results this year. Small molecule, pill treatment for Lewy Body Dementia would be a godsend to a lot of folks.

Ilovebadjokes

CGTX was disappointing

Apprehensive_Fox4115

Least loss is 32% down and only gets me 40 bucks back as I had a seriously small position in it. Next is 42%, CGTX will get me $150 back

EffectiveSlacker

NEWS $Cognition Therapeutics (CGTX.US)$ Cognition Therapeutics Publishes Phase 2 Clinical Results Showing Zervimesine's Potential to Slow the Progression of Dementia with Lewy Bodies

Ilovebadjokes

CGTX going up!

Ilovebadjokes

CGTX news looks exciting but i guess only to me because there’s not alot of volume lol

42percentBicycle

CGTX with positive phase 2 results [Cognition Therapeutics Publishes Phase 2 Clinical Results Showing Zervimesine’s Potential to Slow the Progression of Dementia with Lewy Bodies](https://finance.yahoo.com/news/cognition-therapeutics-publishes-phase-2-123000299.html)

Purple-Comment-3040

It's CGTX (Cognition Therapeutics Inc.)

jer_nyc84

CGTX deserves a callout.

42percentBicycle

CGTX too

Smaybe39

CGTX. Awaiting phase 3 trials and has huge upside.

Thick_Expression_796

TMC, DNN, BITF, CGTX, LAES. My lotto pick is GPUS.

Prestigious_Age5422

Just bought some CGTX because Renaissance Tech bought a lot. 🚀🙏🏻

D3athMerchant

Cognitive Therapeutics CGTX once Phase 3 results come in, that shit is gonna 3X (at minimum)

Funny-Conclusion-678

Biotech is always binary. If they fail at the catalyst, it tanks. It’s risky. I made out well on CGTX. This whole subreddit is just dedicated to getting lucky scalping small term gains on stocks that are picking up speed in pre market. I DO wish I would have threw my life savings into BYND during the decent squeeze tho.

Narcah

CGTX. I’m going to buy a new truck if they actually market their drug. Or I’m going to lose a new truck if they can’t. Guess we’ll see lol.

Maximum-Tone164

Things I'm watching, going into the weekend: BEEM, CETX, CGTX, PLUG, RVPH, SCWO.

Regular_Hawk8513

CGTX has long term potential.

ElmoLovesGrover

Don't know XPON, OSTX. CGTX and GNS are OK. ATCH is actually good! BURU, VIVK could bounce who knows? Don't know what your entry is on those two if they can bounce enough to get your money back. There are garbage companies though.

Equivalent_Monk_7215

Which of my bags are unrecoverable? BURU XPON ATCH CGTX GNS OSTX VIVK

theSelfAloneExists

CGTX.

42percentBicycle

I know people don't really like long term holds here, and they really don't like biotech, but I really think CGTX is worth checking into. They are a legitimate company working to tackle Alzheimer's and other dementia illnesses. [Cognition Therapeutics Presents Phase 3 Plan for Zervimesine (CT1812) in Alzheimer’s Disease at Clinical Trials on Alzheimer’s Disease (CTAD) Conference | Cognition Therapeutics, Inc.](https://ir.cogrx.com/press_releases/cognition-therapeutics-presents-phase-3-plan-for-zervimesine-ct1812-in-alzheimers-disease-at-clinical-trials-on-alzheimers-disease-ctad-conference/) [Cognition Therapeutics Reaches Full Enrollment in Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies | Cognition Therapeutics, Inc.](https://ir.cogrx.com/press_releases/cognition-therapeutics-reaches-full-enrollment-in-expanded-access-program-for-zervimesine-ct1812-in-dementia-with-lewy-bodies/)

Regular_Hawk8513

Should throw CGTX in the long hold position

anthda2

CGTX NUGL CYCU all 10% percent gains! They are supplementing my DFLI haha

42percentBicycle

CGTX reaches full patients enrollment for drug trial. This is a long-term hold that I think has a ton of potential [Cognition Therapeutics Reaches Full Enrollment in Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies](https://finance.yahoo.com/news/cognition-therapeutics-reaches-full-enrollment-123000120.html)

Regular_Hawk8513

CGTX outlined phase 3 plans. This is a strong long term hold

42percentBicycle

Might be worth jumping into CGTX [Cognition Therapeutics Presents Phase 3 Plan for Zervimesine (CT1812) in Alzheimer’s Disease at Clinical Trials on Alzheimer’s Disease (CTAD) Conference](https://finance.yahoo.com/news/cognition-therapeutics-presents-phase-3-123000349.html)

Maximum-Tone164

CGTX, RVPH, CRDF, IBRX. All have variables for continued upward movement.

42percentBicycle

Hoping CGTX gets back up over $3

Maximum-Tone164

CGTX, RVPH, CRDF, IBRX. All have variables for continued upward movement.

True_Signature5352

CGTX or RVPH for ah and the weekend ?

Maximum-Tone164

CGTX. IBRX, CRDF. All have variables that lend to more upward motion, but I anticipate some dip today to scare people off going into the weekend.

Regular_Hawk8513

CGTX continues to rise

Ok_Ground9015

My biggest losers of the year: SPGC/NWTG CGTX ASST (#1 biggest loser. The scam that got me the tax breaks) BYND My biggest winners of the year: IXHL (400%+) bought at .20 and sold at 1.20 made buku thousands. CGTX is ironically in both categories NEGG VVPR had about a 75% win ratio

Regular_Hawk8513

CGTX slowly creeping up today

42percentBicycle

CEO of CGTX will be presenting at healthcare conference on Dec. 3 [Cognition Therapeutics to Participate in 37th Annual Piper Sandler Healthcare Conference](https://finance.yahoo.com/news/cognition-therapeutics-participate-37th-annual-210100737.html)

Ok_Ground9015

Naw. I took some losses on some other plays. I'm not saying that it's out of the realm of possibility that I take a loss on VIVK, but it'll have to go a good bit lower. In the past 3 months or so, I lost 1000 on BYND, 4000 on ASST, and 4000 on CGTX or some other shit, I can't remember. I do know that there are people here still in ASST, because they are stupid. That company is straight scam. They do not give a single solitary fuck about shareholders.

IllustratorFuzzy1483

CGTX

ForeverInTheSun82647

So far, GPUS, CTM, CGTX, DFLI,

Difficult_Physics704

Falling knife. My advice. Take your losses and diversify. CELH, CGTX, UPS, B, GEHC, QUBT/IONQ, MBOT.

DirichletComplex1837

This is exactly me with CGTX

Interesting_Mud_8389

That was possibly the best layman's explanation of not only how CT1812 works best, but defines the very reason CGTX remains possibly one of the most underappreciated stocks for investment. I am big into Anavex as well, but their LBD application alone is worth billions given no other competition and the superb results seen thus far. I believe their P3 trials for p-tau 217 as a target population will fast track for FDA approval. While risky, given both ALZ and LBD applications this stock can easily 10X++. Superb write up.

jer_nyc84

CGTX actually has a shot out of all those.

Low-Pain-9096

My top 3 penny stocks back in June were NEHC(which is now NUAI and had bought 10k shares for 0.47 and sold them at 0.55 to get in the IXHL craze, which flopped and NEHC went to become NUAI and look at it now) IXHL which i mentioned, and CGTX(this one went from 60c to over 3$, currently 1.65). Getting into BioPharma stocks (ixhl&cgtx) is what opened the gate for me to be more curious about more, which is how i ended falling into INTS after it crashed, i thought it was a great opportunity. I also bought 20k shares of OTLK after it crashed from 3$ to 0.8 cents, currently 1.24 which is cool 🤩 I’m currently bagholding IXHL & PSTV & BTOG & BNKK, I can get profits from INTS & OTLK anytime I guess. P.S. BNKK was SHOT before, could be a bad stock pick, but my gut feeling made me do it. All of this is NOT financial advice, just my personal adventure

Status-Cover5949

I’m probably regarded but DFLI, CTM, BYND, CGTX, ICU, AIRE, ENLV, and ATCH. Just adding like 5-10 shares each at a time

Difficult_Physics704

AMZN will make its run to 250-260 this week probably DVLT has been good for me and is a hold for me. OPEN next run will go to 15 DFLI, CGTX, IRBT, AIIO are also apart of my plays. Feel free to do your own dd but they've been good plays so far.

Darkrath_3

CGTX if you're willing to wait.

Trading_4_Kabob

This but I go further and look into the company’s posted at the strategy and future potential level. In the case of something like BYND(I coulda bought at $.6 but didn’t, sometimes you miss out) the fundamentals of the company made me doubt the projections. Beyond Meat has been sold in so many stores Walmart adding on don’t seem like the impact play everyone made it out to be. I didn’t like the fact that it was an empty hype train and didn’t buy. Your own research may have been different there and you’d have made 13x. The idea around penny’s is multifaceted and complex, but it’s also simple. It’s cheap and you can make money on a good price increase. I personally got into stuff like DVLT and CGTX because though they may not be instant gratification, I saw potential for fundamental price increases not hype based one’s.

Funclenumber1

Hey u/martinshkreli let’s get your thoughts and DD on SPRB and CGTX

Darkrath_3

CGTX.

42percentBicycle

CGTX for long term hold

NoRhubarb2277

As a side note, CGTX is moving today too

WV_Wylde

Hold CGTX- it goes up and down but if you do your DD big things will happen. Patience. I wouldn’t say ITRM is a lost cause- couple of good earnings, a partnership, or a bo and this one will go up. It’s an FDA approved brand spanking new antibiotic class. They get a broader use and this one will have crazy earnings.

Pale-Damage-2835

Ya don't say eh. Especially when they spam it. There are some good posts on here. i found CGTX, DFLI, DVLT and RVPH on here and got in when they were low. But I also did a lot of research and not click and buy haha.

Rrrrrrrrrrrrrrrrr11

HOLD CGTX , amazing pipeline , good company.

NoRhubarb2277

CGTX is just looking promising to me. Holding some at 1.75, hoping they drop positive data soon.

Fragrant-Calendar-77

I didn't specifically compare CGTX with Quantum Sector Companies. I know very well that they are totally different sectors and that they have nothing to do with each other. I was referring to the topic of the post "the calm before the storm". I wanted to make a parable/comparison with the moments in which CGTX shares, which have not seen any movement in recent weeks, have the same movement as Quantum shares, which were also not moving and which suddenly started moving upwards, and that the same could happen with CGTX shares. I simply compared the moment and not the companies themselves

CanadianGoku33

This is like comparing apple to oranges lol comparing biotech to quantum computing is ridiculous. I'm a CGTX invester and believe in it aswell but this is just a horrible take. If CGTX starts mooning it has absolutely nothing to do with the companies you just named.

Fragrant-Calendar-77

So a storm (in the good sense of the word) could be on its way to CGTX